These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25943981)

  • 1. The thalamus as a putative biomarker in neurodegenerative disorders.
    Power BD; Looi JC
    Aust N Z J Psychiatry; 2015 Jun; 49(6):502-18. PubMed ID: 25943981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a protocol for manual segmentation of the thalamus on magnetic resonance imaging scans.
    Power BD; Wilkes FA; Hunter-Dickson M; van Westen D; Santillo AF; Walterfang M; Nilsson C; Velakoulis D; Looi JC
    Psychiatry Res; 2015 Apr; 232(1):98-105. PubMed ID: 25752844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACR Appropriateness Criteria Dementia and Movement Disorders.
    Wippold FJ; Brown DC; Broderick DF; Burns J; Corey AS; Deshmukh TK; Douglas AC; Holloway K; Jagadeesan BD; Jurgens JS; Kennedy TA; Patel ND; Perlmutter JS; Rosenow JM; Slavin K; Subramaniam RM
    J Am Coll Radiol; 2015 Jan; 12(1):19-28. PubMed ID: 25557568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
    Lagodka A; Robert P
    Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the thalamus in schizophrenia from a neuroimaging perspective.
    Pergola G; Selvaggi P; Trizio S; Bertolino A; Blasi G
    Neurosci Biobehav Rev; 2015 Jul; 54():57-75. PubMed ID: 25616183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroimaging and traumatic brain injury: State of the field and voids in translational knowledge.
    Bruce ED; Konda S; Dean DD; Wang EW; Huang JH; Little DM
    Mol Cell Neurosci; 2015 May; 66(Pt B):103-13. PubMed ID: 25827094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging insights into network-based neurodegeneration.
    Greicius MD; Kimmel DL
    Curr Opin Neurol; 2012 Dec; 25(6):727-34. PubMed ID: 23108250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers: a new approach to behavioural variant frontotemporal dementia.
    Fernández-Matarrubia M; Matías-Guiu JA; Moreno-Ramos T; Matías-Guiu J
    Neurologia; 2015; 30(1):50-61. PubMed ID: 23648384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in neurodegenerative dementias.
    McGinnis SM
    Semin Neurol; 2012 Sep; 32(4):347-60. PubMed ID: 23361481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of biomarkers for multiple sclerosis as a neurodegenerative disorder.
    Ziemann U; Wahl M; Hattingen E; Tumani H
    Prog Neurobiol; 2011 Dec; 95(4):670-85. PubMed ID: 21524682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olfactory dysfunctions in neurodegenerative disorders.
    Ruan Y; Zheng XY; Zhang HL; Zhu W; Zhu J
    J Neurosci Res; 2012 Sep; 90(9):1693-700. PubMed ID: 22674288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimaging and thalamic connectomics in epilepsy neuromodulation.
    Middlebrooks EH; He X; Grewal SS; Keller SS
    Epilepsy Res; 2022 May; 182():106916. PubMed ID: 35367691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Striatal morphology as a biomarker in neurodegenerative disease.
    Looi JC; Walterfang M
    Mol Psychiatry; 2013 Apr; 18(4):417-24. PubMed ID: 22584865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimensional Neuroimaging Endophenotypes: Neurobiological Representations of Disease Heterogeneity Through Machine Learning.
    Wen J; Antoniades M; Yang Z; Hwang G; Skampardoni I; Wang R; Davatzikos C
    Biol Psychiatry; 2024 Oct; 96(7):564-584. PubMed ID: 38718880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C9orf72-related disorders: expanding the clinical and genetic spectrum of neurodegenerative diseases.
    Souza PV; Pinto WB; Oliveira AS
    Arq Neuropsiquiatr; 2015 Mar; 73(3):246-56. PubMed ID: 25807132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural assessment of thalamus morphology in brain disorders: A review and recommendation of thalamic nucleus segmentation and shape analysis.
    Boelens Keun JT; van Heese EM; Laansma MA; Weeland CJ; de Joode NT; van den Heuvel OA; Gool JK; Kasprzak S; Bright JK; Vriend C; van der Werf YD
    Neurosci Biobehav Rev; 2021 Dec; 131():466-478. PubMed ID: 34587501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in cerebrospinal fluid for synucleinopathies, tauopathies, and other neurodegenerative disorders.
    Marques TM; Van Rumund A; Kuiperij HB; Verbeek MM
    Handb Clin Neurol; 2017; 146():99-113. PubMed ID: 29110782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems approach to neurodegenerative disease biomarker discovery.
    Lausted C; Lee I; Zhou Y; Qin S; Sung J; Price ND; Hood L; Wang K
    Annu Rev Pharmacol Toxicol; 2014; 54():457-81. PubMed ID: 24160693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging signature of neuropsychiatric disorders.
    Worbe Y
    Curr Opin Neurol; 2015 Aug; 28(4):358-64. PubMed ID: 26110796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.